Siga Technologies (SIGA) Income from Continuing Operations (2010 - 2025)
Siga Technologies (SIGA) reported Income from Continuing Operations of 6365819.0 for Q3 2025, down 573.67% on a YoY basis from 1343945.0 in Q3 2024, and down 117.95% quarter-over-quarter from 35472173.0 in Q2 2025.
Siga Technologies (SIGA) Income from Continuing Operations (2010 - 2025) Analysis & Trends
Siga Technologies has reported Income from Continuing Operations for 16 years, with the latest figure at 6365819.0 in Q3 2025.
- For the quarter ending Q3 2025, Income from Continuing Operations fell 573.67% year-over-year to 6365819.0; the trailing twelve-month figure through Sep 2025 stood at 74496254.0 (down 13.09% YoY), and the FY2024 full-year result was 59214216.0, down 13.01% from the prior year.
- Income from Continuing Operations for Q3 2025 stood at 6365819.0, down from 35472173.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 73212356.0 in Q4 2021, with the low at 6365819.0 in Q3 2025.
- Historically, Income from Continuing Operations has averaged 13652273.26 across 5 years, with a median of 167606.0 in 2021.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations surged 9000.73% — and 2025, when it sank 573.67%.
- Siga Technologies' Income from Continuing Operations stood at 73212356.0 in 2021, then slumped by 101.11% to 811794.0 in 2022, then surged by 9000.73% to 72255625.0 in 2023, then sank by 36.67% to 45760315.0 in 2024, then sank by 113.91% to 6365819.0 in 2025.
- The last three Income from Continuing Operations figures came in at 6365819.0 (Q3 2025), 35472173.0 (Q2 2025), and 370415.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Siga Technologies | 314.73 Mn | 159.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -6.37 Mn |
| Jun 30, 2025 | 35.47 Mn |
| Mar 31, 2025 | -370,415.00 |
| Dec 31, 2024 | 45.76 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 10.32 Mn |
| Dec 31, 2023 | 72.26 Mn |
| Sep 30, 2023 | -393,066.00 |
| Jun 30, 2023 | -2.85 Mn |
| Mar 31, 2023 | -918,255.00 |
| Dec 31, 2022 | -811,794.00 |
| Sep 30, 2022 | 33.04 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | -364,455.00 |
| Dec 31, 2021 | 73.21 Mn |
| Sep 30, 2021 | -3.08 Mn |
| Jun 30, 2021 | 167,606.00 |
| Mar 31, 2021 | -812,105.00 |
| Dec 31, 2020 | 20.18 Mn |